Newsroom
Read our latest press releases on partnerships, product launches, and company milestones.
Xenometrix Ames mutagenicity test modernizes this regulatory-aligned NAM within the 3RnD digital ecosystem.
Read more
GenEvolutioN's Micronucleus Genotoxicity screen strengthens 3RnD as a unified platform for chemical safety decision-making.
Licensed scientific and clinical trial data from Redpine is integrated into 3RnD to support AI driven discovery and better decisions.
Partnership integrates Hesperos Human-on-a-Chip® organ systems with AsedaSciences' 3RnD® platform for faster, more human-relevant decision-making.
Unified AI-powered platforms will link hundreds of data sources to deliver high-resolution insights into disease, targets, compounds, and safety.
AssayQuant's KinSight™ Kinome profiling will be integrated into AsedaSciences' 3RnD® platform, enhancing data visualization to accelerate decisions.
